Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Status update in the use of cell-penetrating peptides for the delivery of macromolecular therapeutics
doi: 10.1084/jem.20110462 77 LiuH-PCaoATFengTLiQZhangWYaoSet al
6 FASEB Journal (PubMed)Active-site mapping of thymosin beta-4 fragments for angiogenesis and cell migration
How did Bulletproof take Silicon Valley, Wall Street, and Hollywood by storm
The PK-PD disconnect why short half-life doesnt limit efficacy The striking feature of BPC-157 research is the disparity between short serum presence and sustained tissue-level effects
US$ 26.85
US$ 23.60
US$ 29.50
US$ 24.68
US$ 21.13
US$ 24.62
